Loading company
Loading
Latest annual · FY2020
Millions- Total revenues
- 0
- Operating income
- (9)
- Net income
- (9)
- Free cash flow
- (8)
Latest quarter · Q3 FY2026
Millions- Free cash flow
- (2)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2020 to FY2025
- n/m
Phio Pharmaceuticals Corp. (PHIO) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Operating income | -$9.2 million | -$7.4 million | 10-K 2026-03-05 · proof | |
| Net income | -$8.7 million | -$7.2 million | 10-K 2026-03-05 · proof | |
| Cash from operating activities | -$8 million | -$7.1 million | 10-K 2026-03-05 · proof | |
| Free cash flow | -$8 million | -$7.1 million | 10-K 2026-03-05 · proof | |
| Total assets | $21.5 million | $5.7 million | +274.5% | 10-K 2026-03-05 · proof |
| Total liabilities | $1.3 million | $1 million | +32% | 10-K 2026-03-05 · proof |
| Cash and cash equivalents | $21 million | $5.4 million | +290.8% | 10-K 2026-03-05 · proof |
- What was Phio Pharmaceuticals Corp. (PHIO)'s operating income in fiscal 2025?
- Phio Pharmaceuticals Corp. (PHIO) reported operating income of -$9.2 million for fiscal 2025 (the year ended Dec 31, 2025), against -$7.4 million the year before. Source: the 10-K filed with the SEC on Mar 5, 2026. SEC
- What was Phio Pharmaceuticals Corp. (PHIO)'s net income in fiscal 2025?
- Phio Pharmaceuticals Corp. (PHIO) reported net income of -$8.7 million for fiscal 2025 (the year ended Dec 31, 2025), against -$7.2 million the year before. Source: the 10-K filed with the SEC on Mar 5, 2026. SEC
- What was Phio Pharmaceuticals Corp. (PHIO)'s cash from operating activities in fiscal 2025?
- Phio Pharmaceuticals Corp. (PHIO) reported cash from operating activities of -$8 million for fiscal 2025 (the year ended Dec 31, 2025), against -$7.1 million the year before. Source: the 10-K filed with the SEC on Mar 5, 2026. SEC
- What was Phio Pharmaceuticals Corp. (PHIO)'s free cash flow in fiscal 2025?
- Phio Pharmaceuticals Corp. (PHIO) reported free cash flow of -$8 million for fiscal 2025 (the year ended Dec 31, 2025), against -$7.1 million the year before. Source: the 10-K filed with the SEC on Mar 5, 2026. SEC
- What are Phio Pharmaceuticals Corp. (PHIO)'s total assets?
- As of Dec 31, 2025, Phio Pharmaceuticals Corp. (PHIO) reported total assets of $21.5 million, against $5.7 million a year earlier (+274.5%). Source: the 10-K filed with the SEC on Mar 5, 2026. SEC
- What are Phio Pharmaceuticals Corp. (PHIO)'s total liabilities?
- As of Dec 31, 2025, Phio Pharmaceuticals Corp. (PHIO) reported total liabilities of $1.3 million, against $1 million a year earlier (+32%). Source: the 10-K filed with the SEC on Mar 5, 2026. SEC
- What are Phio Pharmaceuticals Corp. (PHIO)'s cash and cash equivalents?
- As of Dec 31, 2025, Phio Pharmaceuticals Corp. (PHIO) reported cash and cash equivalents of $21 million, against $5.4 million a year earlier (+290.8%). Source: the 10-K filed with the SEC on Mar 5, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:PHIO&period_type=annual&limit=5"Information only, not investment advice.